Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Dia-Präsentation von Serono Austria GMBH
EVIDENCE-Umstellungsstudie (22 Abbildungen)
Übersicht
Gesamtpräsentation zum Download (rechte Maustaste und "Ziel speichern unter..." klicken)


Zum ersten Bild Abb. 13: Schubrate Abb. 14: Umstellung Avonex - Rebif Abb. 15: MRT-Ergebnisse  - Rebif Aktuelles Bild - Abb. 16: MRT-Ergebnisse - Umstellung - Avonex - Rebif Abb. 17: EVIDENCE-Umstellung Abb. 18: Nebenwirkungen Abb. 19: Umstellung - Behandlungsabbrüche Zum letzten Bild
Abbildung 16: MRT-Ergebnisse - Umstellung - Avonex - Rebif
‘n’ of 188 reflects number of patients in post transition group (223) who had scans performed – not all patients had scans during EVIDENCE and a number of scans are missing due to errors at site in terms of when scans were to be done. Y-axis shows either T2 count per patient per scan or the proportion of scans active per patient– values are means (median for T2 lesions and % T2 active scans are both 0). Data shows there is a substantial and immediate effect of switching from 30 qw to 44 tiw.
 
MRT-Ergebnisse - Umstellung - Avonex - Rebif
Vorheriges Bild Nächstes Bild   


Abbildung 16: MRT-Ergebnisse - Umstellung - Avonex - Rebif
‘n’ of 188 reflects number of patients in post transition group (223) who had scans performed – not all patients had scans during EVIDENCE and a number of scans are missing due to errors at site in terms of when scans were to be done. Y-axis shows either T2 count per patient per scan or the proportion of scans active per patient– values are means (median for T2 lesions and % T2 active scans are both 0). Data shows there is a substantial and immediate effect of switching from 30 qw to 44 tiw.
 
copyright © 2003–2017 Krause & Pachernegg GmbH | Sitemap | Impressum
 
Werbung